Clinical Trials Browser

Phase 2 × Interventional × Breast Diseases × Clear all

NCT06335069 2025-09-24

18F-FDG Versus 68Ga-FAPI-46 as PET Tracer in ER-positive Breast Cancer.

Phase 2 Recruiting

Breast Diseases, Breast Neoplasms

NCT04605575 2022-04-26

Pyrotinib Plus Vinorelbine in Participants With HER2-positive Previously Treated Locally Advanced or Metastatic Breast Cancer

Phase 2 Unknown

Breast Diseases, Breast Neoplasms

NCT01499160 2022-02-11

Letrozole and Lapatinib Followed by Everolimus in Women With Advanced Breast Cancer

Phase 2 Terminated

7 enrolled 6 charts

Breast Diseases, Breast Neoplasms, Neoplasm Metastasis

NCT03910712 2019-04-10

Pyrotinib

Phase 2 Unknown

Breast Diseases, Breast Neoplasms

NCT01472146 2017-05-09

ZoNantax - Zolendronic Acid as Neoadjuvant Therapy Plus Anthracycline and Taxane in Locally Advanced Breast Cancer

Phase 2 Completed

Breast Diseases, Breast Neoplasms, Neoplasms, Neoplasms by Site

NCT00678626 2015-05-04

Phase 2 Trial Of CP-751,871 And Docetaxel In Advanced Breast Cancer

Phase 2 Withdrawn

Breast Diseases, Breast Neoplasms

NCT01043913 2010-01-07

Guarana (Paullinia Cupana) for Breast Cancer Chemotherapy-related Fatigue

Phase 2 Completed

Breast Diseases, Breast Neoplasms, Fatigue, Neoplasms, Neoplasms by Site, Signs and Symptoms